Literature DB >> 33716738

The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival.

Noelia Ruzafa1,2, Xandra Pereiro1,2, Alex Fonollosa1,3,2, Javier Araiz1,2, Arantxa Acera1,4, Elena Vecino1,2.   

Abstract

Plasma rich in growth factors (PRGF) is a subtype of platelet-rich plasma that has being employed in the clinic due to its capacity to accelerate tissue regeneration. Autologous PRGF has been used in ophthalmology to repair a range of retinal pathologies with some efficiency. In the present study, we have explored the role of PRGF and its effect on microglial motility, as well as its possible pro-inflammatory effects. Organotypic cultures from adult pig retinas were used to test the effect of the PRGF obtained from human as well as pig blood. Microglial migration, as well as gliosis, proliferation and the survival of retinal ganglion cells (RGCs) were analyzed by immunohistochemistry. The cytokines present in these PRGFs were analyzed by multiplex ELISA. In addition, we set out to determine if blocking some of the inflammatory components of PRGF alter its effect on microglial migration. In organotypic cultures, PRGF induces microglial migration to the outer nuclear layers as a sign of inflammation. This phenomenon could be due to the presence of several cytokines in PRGF that were quantified here, such as the major pro-inflammatory cytokines IL-1β, IL-6 and TNFα. Heterologous PRGF (human) and longer periods of cultured (3 days) induced more microglia migration than autologous porcine PRGF. Moreover, the migratory effect of microglia was partially mitigated by: 1) heat inactivation of the PRGF; 2) the presence of dexamethasone; or 3) anti-cytokine factors. Furthermore, PRGF seems not to affect gliosis, proliferation or RGC survival in organotypic cultures of adult porcine retinas. PRGF can trigger an inflammatory response as witnessed by the activation of microglial migration in the retina. This can be prevented by using autologous PRGF or if this is not possible due to autoimmune diseases, by mitigating its inflammatory effect. In addition, PRGF does not increase either the proliferation rate of microglial cells or the survival of neurons. We cannot discard the possible positive effect of microglial cells on retinal function. Further studies should be performed to warrant the use of PRGF on the nervous system.
Copyright © 2021 Ruzafa, Pereiro, Fonollosa, Araiz, Acera and Vecino.

Entities:  

Keywords:  cytokines; glia; inflammation; microglia; neuron; ophthalmology; plasma rich in growth factors; retina

Year:  2021        PMID: 33716738      PMCID: PMC7953148          DOI: 10.3389/fphar.2021.606232

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  93 in total

Review 1.  Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System.

Authors:  Hideki Hayashi; Norio Takagi
Journal:  Biol Pharm Bull       Date:  2015       Impact factor: 2.233

Review 2.  Retinal microglia: just bystander or target for therapy?

Authors:  Marcus Karlstetter; Rebecca Scholz; Matt Rutar; Wai T Wong; Jan M Provis; Thomas Langmann
Journal:  Prog Retin Eye Res       Date:  2014-12-02       Impact factor: 21.198

Review 3.  Glia-neuron interactions in the mammalian retina.

Authors:  Elena Vecino; F David Rodriguez; Noelia Ruzafa; Xandra Pereiro; Sansar C Sharma
Journal:  Prog Retin Eye Res       Date:  2015-06-23       Impact factor: 21.198

4.  Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation.

Authors:  Sophia Bardehle; Martin Krüger; Felix Buggenthin; Julia Schwausch; Jovica Ninkovic; Hans Clevers; Hugo J Snippert; Fabian J Theis; Melanie Meyer-Luehmann; Ingo Bechmann; Leda Dimou; Magdalena Götz
Journal:  Nat Neurosci       Date:  2013-03-31       Impact factor: 24.884

5.  Retinal ganglion cell loss is size dependent in experimental glaucoma.

Authors:  Y Glovinsky; H A Quigley; G R Dunkelberger
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-03       Impact factor: 4.799

Review 6.  Pro- versus anti-inflammatory cytokines: myth or reality.

Authors:  J M Cavaillon
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2001-06       Impact factor: 1.770

7.  Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion.

Authors:  E Anitua; M M Zalduendo; R Prado; M H Alkhraisat; G Orive
Journal:  J Biomed Mater Res A       Date:  2014-06-12       Impact factor: 4.396

8.  Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats.

Authors:  Francisco M Nadal-Nicolás; Manuel Jiménez-López; Manuel Salinas-Navarro; Paloma Sobrado-Calvo; Juan J Alburquerque-Béjar; Manuel Vidal-Sanz; Marta Agudo-Barriuso
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

9.  Inflamed In Vitro Retina: Cytotoxic Neuroinflammation and Galectin-3 Expression.

Authors:  Patrik Maximilian Bauer; Marina Castro Zalis; Hodan Abdshill; Tomas Deierborg; Fredrik Johansson; Ulrica Englund-Johansson
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

Review 10.  Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities.

Authors:  Anne-Laure Hemonnot; Jennifer Hua; Lauriane Ulmann; Hélène Hirbec
Journal:  Front Aging Neurosci       Date:  2019-08-30       Impact factor: 5.750

View more
  2 in total

1.  Effectiveness of Platelet-Rich Plasma for Patients With Carpal Tunnel Syndrome: A Systematic Review and meta-Analysis of Current Evidence in Randomized Controlled Trials.

Authors:  Jiabao Jiang; Fei Xing; Rong Luo; Ming Liu
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

2.  Impact of blood source and component manufacturing on neurotrophin content and in vitro cell wound healing.

Authors:  Sabrina Valente; Nico Curti; Enrico Giampieri; Vanda Randi; Chiara Donadei; Marina Buzzi; Piera Versura
Journal:  Blood Transfus       Date:  2021-08-03       Impact factor: 5.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.